The aim of this work is to: 1) Determine the viable processing window of HPMC-Affinisol polymer to use in hot melt extrusion. 2) Use this polymer for oral formulations with Paracetamol over a wide range of physical grades and determine the effect of API particle size on the nature of the resulting formulated mixtures. 3) Assess if HME can be used to produce a consistent output with wide ranges in physical input API properties. Methods HPMC (Affinisol™15LV, Dow Chemical Co.) was fed into a Eurolab 16mm co-rotating twin screw extruder at 1kg/hr. A 3mm die was used to produce the extruded strand. Three barrel temperatures (150, 180 and 210°C) were used and the screw speed was adjusted between 100-1000rpm. Torque and pressure generated during extrusion were also monitored. The physical appearance of the extrudate was monitored for discolouration and clarity to determine the viability of the processing conditions for production of the extrudate. Three physical grades of 25% (w/w) of Paracetamol (Mallinckrodt Chemical limited, D(v,0.5): micronized-10.3μm, powder-52.6μm and granular-299μm) were used to produce solid dispersions of the Paracetamol in the polymer at the viable processing conditions determined during polymer extrusion. Differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD) analyses were carried out to assess whether the resulting formulations were amorphous. Physical mixtures of the drug-polymer were also analysed to provide a reference data set.
